Comparing Standard PSA vs Stockholm3 Prostate Test Costs
Compare standard PSA vs Stockholm3 prostate test costs in the UK. Understand what each test measures, who should consider testing, and how results are interpreted.
When it comes to PSA vs Stockholm3 prostate test costs, understanding the difference between these two screening tools can help men in the UK make more informed decisions about their prostate health. Whether you are considering a private blood test for the first time or weighing up your options beyond a standard NHS check, this guide breaks down what each test involves, what it measures, and what factors influence the cost of each approach.
What Is a PSA Test? A Clear Definition
A PSA (Prostate-Specific Antigen) test is a blood test that measures the level of PSA — a protein produced by the prostate gland — in the bloodstream. Elevated PSA levels may indicate a range of prostate conditions, including benign prostatic hyperplasia (BPH), prostatitis, or changes associated with prostate health that warrant further assessment.
PSA testing is widely used as a first-line prostate health indicator. It is simple, affordable, and available through both NHS referral and private screening clinics across London and the UK.
> Snippet Definition: A PSA test measures the concentration of prostate-specific antigen in the blood. Raised levels may suggest prostate changes that could benefit from further review. It is a widely available, cost-effective blood test used in routine men’s health screening.
What Is the Stockholm3 Test?
The Stockholm3 test is a prostate risk assessment tool that goes beyond a single PSA measurement. It combines PSA with additional protein biomarkers, genetic markers, and clinical factors (such as age, family history, and prostate volume) to generate a personalised risk score.
Originally developed in Sweden through a large-scale clinical study, Stockholm3 is designed to improve the prediction of clinically significant prostate cancer while reducing the likelihood of unnecessary follow-up procedures based on a mildly elevated PSA alone.
Stockholm3 is now available in the UK through selected private health screening providers and offers an expanded set of biomarkers for men seeking a more detailed prostate health risk assessment.
Standard PSA vs Stockholm3: Side-by-Side Comparison
| Feature | Standard PSA Test | Stockholm3 Test |
|---|---|---|
| What it measures | PSA protein level in blood | PSA + additional proteins + genetic markers + clinical data |
| Sample type | Blood test | Blood test |
| Result type | Single numerical value (ng/mL) | Personalised risk score (%) |
| Who it suits | Men seeking routine prostate screening | Men with elevated PSA or higher personal risk factors |
| Turnaround | Typically 1–3 working days | Variable; may take longer due to extended analysis |
| Availability in UK | Widely available (NHS & private) | Selected private clinics |
| Cost (private UK) | Lower cost entry point | Higher cost due to multi-biomarker analysis |
| Sensitivity | May produce false positives in some cases | Designed to reduce unnecessary further investigation |
| Compliance | UK standard screening tool | CE-marked; validated in European populations |
Practical Insight: The Stockholm3 test does not replace the PSA test — it builds upon it. For many men, a standard PSA test remains a sensible and accessible starting point for prostate health awareness.
Understanding the Cost Difference: Why Does Stockholm3 Cost More?
The cost difference between a standard PSA blood test and the Stockholm3 test reflects several practical factors:
- Number of biomarkers analysed: Stockholm3 analyses multiple proteins alongside PSA, increasing laboratory processing complexity.
- Genetic marker inclusion: Incorporating SNP (single nucleotide polymorphism) data requires additional genomic analysis.
- Clinical algorithm: Results are processed through a validated risk algorithm, not simply reported as a raw number.
- Reporting detail: Stockholm3 reports typically include a personalised risk percentage and a recommended next-step indication.
For men in London and across the UK considering private prostate screening, the standard PSA test offers a cost-effective and clinically recognised starting point. Stockholm3 may be worth considering for those who have previously had a borderline PSA result or who have known risk factors such as a family history of prostate cancer. Suitability depends on individual clinical circumstances.
To compare pathways before you book, start with our guide on when to start annual PSA testing in the UK.
Who Should Consider Each Test?
Standard PSA Testing May Be Appropriate For:
- Men aged 45 and over seeking a routine prostate health baseline
- Men with no prior history of elevated PSA
- Those seeking an affordable entry point to prostate screening
- Men who want to track their PSA levels over time
Stockholm3 Testing May Be Worth Considering For:
- Men with a previously raised or borderline PSA result
- Those with a first-degree relative (father or brother) diagnosed with prostate cancer
- Men of Black African or Black Caribbean heritage, who carry a statistically higher prostate cancer risk
- Individuals seeking a more detailed risk profile before any further clinical decisions
Practical Insight: Neither test provides a diagnosis. Both are screening and risk-assessment tools that generate information to support informed conversations with an appropriate healthcare professional.
How Often Should Men Be Tested?
Screening frequency is a personal decision that may be guided by your age, risk profile, and previous results.
General guidance (for illustrative purposes only — individual screening frequency should always be determined in consultation with an appropriately qualified healthcare professional):
- Routine PSA screening: Many private clinics suggest annual or biennial testing for men over 50, or from age 45 for those in higher-risk groups.
- Follow-up after Stockholm3: The Stockholm3 test itself may suggest a recommended review interval based on the risk score generated.
- After a borderline result: Men who receive a borderline or slightly elevated PSA may benefit from repeat testing at a shorter interval, as recommended by their healthcare professional.
If you are considering proactive monitoring, our prostate health monitoring guide offers practical context before repeat testing.
What Do the Results Mean?
Understanding Your PSA Result
PSA is measured in nanograms per millilitre (ng/mL). There is no universally agreed "normal" level, as PSA naturally rises with age. However, as a general guide:
| Age Group | PSA Level That May Warrant Review |
|---|---|
| Under 50 | Above 2.5 ng/mL |
| 50–59 | Above 3.5 ng/mL |
| 60–69 | Above 4.5 ng/mL |
| 70 and over | Above 6.5 ng/mL |
These figures are indicative only and should not be used for self-diagnosis.
A raised PSA may suggest a number of prostate-related changes. It does not confirm the presence of any specific condition. Our clinic provides clear, written results reports to help you understand your findings.
Understanding Your Stockholm3 Score
Stockholm3 generates a percentage risk score. A score above a defined threshold (typically 11% in clinical validation studies) may suggest that further clinical assessment could be appropriate. A lower score may indicate a reduced probability of clinically significant findings at that time, though it does not exclude the possibility of prostate changes requiring future assessment.
Practical Insight: Results from either test should always be reviewed in the context of your personal health history. Our nurse-led team can discuss your results report and help you understand next steps.
London-Based Private Prostate Screening: What to Expect
For men across London seeking private prostate health screening, access to both PSA and Stockholm3 testing is available without a GP referral. Private screening clinics offer:
- Nurse-led consultations in a confidential setting
- Clear written results reports
- Guidance on appropriate next steps following your results
At Health Screening Clinic, our nurse-led team provides prostate blood testing and detailed results reporting in a professional, supportive environment. We do not offer prescriptions, treatments, or specialist referrals — our focus is on providing accurate, accessible testing information to support your health decisions.
Men based in London who are exploring broader wellbeing monitoring may also find our screening packages useful as a starting point.
Frequently Asked Questions
What is the main difference between a PSA test and Stockholm3?
A standard PSA test measures a single protein in the blood. Stockholm3 combines PSA with additional protein biomarkers, genetic markers, and personal health data to produce a personalised prostate cancer risk score. Stockholm3 is designed to provide a more detailed risk picture than PSA alone.
Is the Stockholm3 test available on the NHS?
As of publication, the Stockholm3 test is not routinely available on the NHS in England. It is available through selected private health screening providers in the UK.
Why does the Stockholm3 test cost more than a standard PSA test?
The higher cost reflects the greater number of biomarkers analysed, the inclusion of genetic markers, and the validated risk algorithm used to generate a personalised result. The additional complexity of the test is reflected in the price.
Can I have a PSA test without a GP referral in the UK?
Yes. Private health screening clinics in the UK, including those in London, offer PSA blood testing without the need for a GP referral. Results are typically available within a few working days.
What does a raised PSA result mean?
A raised PSA level may indicate a range of prostate-related changes, including benign conditions such as an enlarged prostate or inflammation. It does not confirm any specific condition. Anyone with a raised PSA result is encouraged to seek guidance from an appropriately qualified healthcare professional.
How often should I have a prostate blood test?
Frequency depends on your age, personal risk factors, and previous results. Many clinics suggest annual screening for men over 50 or from 45 for those in higher-risk groups. Discuss your individual circumstances with a healthcare professional.
Is the Stockholm3 test suitable for all men?
Stockholm3 is most commonly recommended for men with a borderline or elevated PSA result, a family history of prostate cancer, or those who belong to higher-risk population groups. A standard PSA test is often a sensible first step for men with no prior screening history.
Does a high Stockholm3 score mean I have prostate cancer?
No. Stockholm3 generates a risk score, not a diagnosis. A higher score may suggest that further clinical assessment could be appropriate, but it does not confirm the presence of any condition. All results should be reviewed with an appropriate healthcare professional.
Can I book a PSA or Stockholm3 test at Health Screening Clinic?
Yes. Health Screening Clinic offers nurse-led prostate blood testing and results reporting. You can book a prostate health screening appointment to review current options.
What is the difference in turnaround time between PSA and Stockholm3?
A standard PSA result is typically available within 1–3 working days. Stockholm3 results may take longer due to the extended multi-biomarker and genetic analysis involved. Specific turnaround times will be confirmed at the time of booking.
Take a Proactive Approach to Your Prostate Health
Prostate health screening is a practical and positive step that many men across the UK are choosing to take earlier and more regularly. Whether you are considering a standard PSA blood test as a baseline or exploring whether Stockholm3 may offer additional insight for your individual risk profile, access to clear, nurse-led screening is available without waiting.
If you want a broader prevention perspective, read why earlier prostate cancer detection can improve outcomes before planning your next screening interval.
About This Content
This article has been written by a senior UK medical content specialist with expertise in preventive health screening and diagnostic blood testing. All information is grounded in current UK clinical guidance and is intended to support health literacy and informed decision-making. This content is reviewed regularly to ensure alignment with evolving UK healthcare standards.
Educational content only. It is not medical advice, diagnosis, or treatment. Health Screening Clinic provides testing and reporting services only. Please discuss symptoms or abnormal results with a qualified healthcare professional.